Abstract
Background
Coagulopathy and platelet dysfunction commonly develop after traumatic brain injury (TBI). Thromboelastography (TEG) and platelet function assays (PFAs) are often performed at the time of admission; however, their roles in assessing post-TBI coagulopathy have not been investigated. We hypothesized that compared to blunt TBI, penetrating TBI would (1) demonstrate greater coagulopathy by TEG, (2) be associated with abnormal PFA results, and (3) require more blood product transfusions.
Methods
We performed a retrospective study of patients admitted to the neuroscience intensive care unit of a level 1 trauma center from 2013 to 2015 with head Abbreviated Injury Scale ≥3. Patients were compared by mechanism of injury (blunt vs. penetrating). Admission demographics, injury characteristics, and laboratory parameters were evaluated. VerifyNow® Aspirin and P2Y12 tests were used for platelet function analysis.
Results
Five hundred and thirty-four patients were included in the analysis. There were no differences between groups in platelet count or international normalized ratio; however, patients with penetrating TBI were more coagulopathic by TEG, with all of the TEG parameters being significantly different except for R time. Patients with penetrating head trauma were not more likely than their blunt counterparts to have abnormal PFA results, and PFA results did not correlate with any TEG parameter in either group. The penetrating cohort received more units of blood products in the first 4 and 24 h than the blunt cohort.
Conclusions
Patients presenting with penetrating TBI demonstrated increased coagulopathy compared to those with blunt TBI as measured by TEG and need for transfusion. PFA results did not correlate with TEG findings in this population.
Similar content being viewed by others
References
Boto G, Gomez P, De La Cruz J, Lobato R. Severe head injury and the risk of early death. J Neurol Neurosurg Psychiatry. 2006;77:1054–9.
Centers for Disease Control and Injury Prevention. Traumatic Brain Injury. http://www.cdc.gov/traumaticbraininjury/statistics.html. Accessed Jan 12, 2014.
Lustenberger T, Talving P, Kobayashi L, Barmparas G, Inaba K, Lam L, Branco B, Demetriades D. Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged. J Trauma. 2010;69:1410–4.
Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan L, Demetriades D. Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma. 2009;66:55–61.
Wafaisade A, Lefering R, Tjardes T, Wutzler S, Simanski C, Paffrath T, Fischer P, Bouillon B, Maegele M. Acute coagulopathy in isolated blunt traumatic brain injury. Neurocrit Care. 2009;12:211–9.
Oertel M, Kelly DF, McArthur D, Boscardin W, Glenn T, Lee J, Gravori T, Obukhov D, McBride D, Martin N. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg. 2002;96:109–16.
Abdelfattah K, Cripps M. Thromboelastography and rotational thromboelastometry use in trauma. Int J Surg. 2016;33:196–201.
Hans G, Besser M. The place of viscoelastic testing in clinical practice. Br J Haematol. 2016;173:37–48.
Massaro AM, Doerfler S, Nawalinski K, Driscoll N, Ju C, Patel H, Quattrone F, Frangos S, Maloney-Wilensky E, Sean Grady M, Stein SC, Kasner SE, Kumar MA. Thromboelastography defines late hypercoagulability after TBI: a pilot study. Neurocrit Care. 2015;22:45–51.
Folkerson LE, Sloan D, Cotton BA, Holcomb JB, Tomasek JS, Wade CE. Predicting progressive hemorrhage injury from isolated traumatic brain injury and coagulation. Surgery. 2015;158:655–61.
Paniccia R, Priora R, Liotta A, Abbate R. Platelet function tests: a comparative review. Vasc Health Risk Manag. 2015;11:133–48.
Harrison P, Segal H, Blasbery K, Furtado C, Silver L, Rothwell P. Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry. J Stroke. 2005;36:1001–5.
Jeong Y, Bliden K, Antonino M, Park K, Tantry U, Gurbel P. Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. Am Heart J. 2012;164:35–42.
Wohlauer M, Moore E, Thomas S, Sauaia A, Evans E, Harr J, Silliman C, Ploplis V, Castellino F, Walsh M. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg. 2012;214:739–46.
Kutcher M, Redick B, McCreery R, Crane I, Greenberg M, Cachola L, Nelson M, Cohen M. Characterization of platelet dysfunction after trauma. J Trauma Acute Care Surg. 2012;73:13–9.
Bachelani A, Bautz J, Sperry J, Corcos A, Zenati M, Billiar T, Peitzman A, Marshall G. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery. 2011;150:836–43.
Bansal V, Fortlage D, Lee J, Doucet J, Potenza B, Coimbra R. A New Clopidogrel (Plavix) Point-of-care assay: rapid determination of antiplatelet activity in trauma patients. J Trauma. 2011;70:65–70.
Oestreich J, Holt J, Dunn S, Smyth S, Campbell C, Chamigo R, Akers W, Steinhubl S. Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel. Coron Artery Dis. 2009;20:207–13.
Ben-Dor I, Kleiman N, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol. 2009;104:227–33.
Serebruany V, Steinhubl S, Berger P, Malinin A, Bhatt D, Topol E. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol. 2005;45:246–51.
Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. J Crit Care. 2010;14:R55.
Kearney T, Bentt L, Grode M, Lee S, Hiatt J, Shabot M. Coagulopathy and catecholamines in severe head injury. J Trauma. 1992;32:608–11.
Nishijima D, Zehtabchi S, Berrong J, Legome E. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J Trauma Acute Care Surg. 2012;72:1658–63.
Washington C, Schuerer D, Grubb R. Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. J Trauma. 2011;71:358–63.
Campbell P, Sen A, Yadla S, Jabbour P, Jallo J. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. World Neurosurg. 2010;74:279–85.
Taylor G, Osinski D, Thevenin A, Devys J. Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery? J Trauma Acute Care Surg. 2013;74:1367–9.
Joseph B, Pandit V, Sadoun M, Larkins C, Kulvatunyou N, Mino M, Friese R, Rhee P. A prospective evaluation of platelet function in patients on antiplatelet therapy with traumatic intracranial hemorrhage. J Trauma Acute Care Surg. 2013;75:990–4.
Briggs A, Gates J, Kaufman R, Calahan C, Gormley W, Havens J. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res. 2015;193:802–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martin, G., Shah, D., Elson, N. et al. Relationship of Coagulopathy and Platelet Dysfunction to Transfusion Needs After Traumatic Brain Injury. Neurocrit Care 28, 330–337 (2018). https://doi.org/10.1007/s12028-017-0485-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-017-0485-5